Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,786,188
+$821,543 QoQ
Shares Held
89,720
-0.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
3.12%
of 13F equity value
Holder Rank
#687
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Estabrook Capital Management holds $58,767,979 across 13 Drug Manufacturers - General names. JNJ ranks #1 (38.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
89,720 | $22,786,188 | |
| 2 | MRK |
Merck & Co., Inc.
|
96,811 | $12,440,213 | |
| 3 | PFE |
Pfizer Inc
|
324,099 | $7,804,303 | |
| 4 | AMGN |
Amgen Inc
|
18,721 | $6,779,248 | |
| 5 | LLY |
ELI LILLY & Co
|
3,705 | $4,443,888 | |
| 6 | ABBV |
AbbVie Inc.
|
12,861 | $3,236,342 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,515 | $548,254 | |
| 8 | BIIB |
Biogen Inc.
|
2,000 | $432,120 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,786,188 | 89,720 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $21,964,645 | 89,857 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $18,644,746 | 90,093 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,968,340 | 91,513 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $14,015,423 | 91,754 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $15,160,429 | 91,416 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $13,502,301 | 93,364 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $15,328,607 | 94,586 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $13,921,155 | 95,246 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $15,158,398 | 95,824 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,051,585 | 96,029 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $15,118,029 | 97,066 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $16,017,204 | 96,769 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $15,015,780 | 96,876 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $17,144,059 | 97,051 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,994,740 | 97,911 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,644,494 | 99,400 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $17,936,384 | 101,204 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $17,362,065 | 101,491 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $16,333,787 | 101,138 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $16,920,610 | 102,711 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $17,034,220 | 103,646 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $15,911,747 | 101,104 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $15,434,687 | 103,672 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $14,825,073 | 105,419 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $14,338,540 | 109,346 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||